Chronic HBV infection (N = 286) | HBV-Spontaneous clearance (N = 135) | Healthy controls (N = 109) | |
---|---|---|---|
Median age (range), y | 42 (19–78) | 52 (19–85) | 53 (25–76) |
Gender (%) | |||
Male | 60.14 | 38.51 | 50.46 |
Female | 39.86 | 61.49 | 49.54 |
Mean Alanine aminotransferase ± SD (IU/L) | 55.66 ± 25.63 | 28.36 ± 6.32 | 26.80 ± 5.72 |
Mean Aspartate aminotransferase ± SD (IU/L) | 48.09 ± 24.87 | 25.93 ± 5.45 | 21.70 ± 2.64 |
HBeAg positive (%) | 5.5 | – | – |
Anti-HBe positive (%) | 94.5 | – | – |
Median log10 HBV-DNA (IU/ml) | 4.4 (3.8-6.5) | – | – |
Genotypes (%) | |||
D | 89 | – | – |
A | 11 | – | – |
SLC10A1 (rs2296651, G > A) | |||
GG | 286 (100%) | 135 (100%) | 109 (100%) |
AG | 0 | 0 | 0 |
AA | 0 | 0 | 0 |